Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini, MD, that found using antihistamines in patients receiving second-line immunotherapy (IO) for bladder ...

for bladder cancer may improve outcomes. The research, published in the journal Urologic Oncology: Seminars and Original Investigations, focused on metastatic urothelial carcinoma (mUC), cancer ...

Trends and demographic disparities in the preferred place of death for bladder cancer patients in the United States (2000–2020): An analysis from the CDC database. This is an ASCO Meeting Abstract ...

During a live event, participating oncologists discuss the role of ctDNA and molecular testing in muscle-invasive bladder ...

Given different scientific and clinical meeting schedules, considering advances in genitourinary oncology in novel therapies ...

Evaluating the contribution of circulating tumor DNA (ctDNA) towards magnetic resonance imaging (MRI) in clinical staging and response assessment of patients with muscle-invasive bladder cancer (MIBC) ...

Dr. Park shares the three biggest takeaways, in his opinion, to have come out of the ASCO GU Symposium, highlighting studies ...

Lung metastases or metastatic cancer to the lung occurs when a cancer that originates in another area of the body, such as the breast or bladder, spreads to the lungs. Most people with lung metastases ...

Late bladder toxicity is a concern for patients receiving prostate cancer radiotherapy and negatively impacts survivors. Few risk factors are known beyond the radiation dose and volume of bladder ...

While significant advances have been made in the treatment of bladder cancer over the last five years, such as the new standard of care in the first-line treatment of metastatic bladder cancer with ...

N1 Single lymph node metastasis, 2 cm or less in greatest ... The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% ...